Table 2.
No treatment delay | 3-month delay | 6-month delay | 9-month delay | |
Mean 1-year VA | 57.8 letters (56.6–59.1) |
52.7 letters (51.4–54.1) (−5.1 letters ; p<0.001) |
50.3 letters (48.8–51.6) (−7.5 letters; p<0.001) |
48.6 letters (47.2–49.9) (−9.2 letters; p<0.001) |
% severe sight impairment (≤35 letters) |
15.5 (13.2–17.9) |
23.3 (20.7–25.9) (+7.8; p<0.001) |
27.6 (24.7–30.6) (+12.1; p<0.001) |
30.8 (28.0–33.7) (+15.3; p<0.001) |
% sight impairment (≤55 letters) |
39.4 (36.1–42.5) |
50.0 (46.9–53.1) (+10.6; p<0.001) |
54.8 (51.5–58.2) (+15.4; p<0.001) |
57.9 (54.7–61.1) (+18.5; p<0.001) |
% driving vision (≥70 letters) |
35.1 (32.1–38.1) |
26.4 (23.8–29.2) (−8.7; p<0.001) |
23.1 (20.6–25.7) (−12.0; p<0.001) |
21.3 (18.7–23.9) (−13.8; p<0.001) |
Comparisons with the no treatment delay model are provided in italics.
VA, visual acuity.